TempraMed

Products for Storing, Carrying and Tracking Medication

Health Tech & Life Sciences
Active
Public Tel Aviv-Yafo Founded 2014
Total raised
$10.2M
Last: PIPE 2025-10
Stage
Public
Founded
2014
Headcount
14
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

TempraMed developed a patent protected technology that can be used in a wide range of Medical/Consumer products, providing temperature control without need for power source or human intervention for years and additionally track medication use. TempraMed already sells products to the first vertical, addressing the need to provide temperature control and management to temperature sensitive injectable medications such as Insulin, EpiPen, Biologics, Hormone, to patients worldwide – a growing market opportunity.

TempraMed’ s product addresses the need of patients, HCP, and payors to make sure medications are tracked and controlled to maintain their potency. While initial target customers for the products are the patients as the products become the standard, they will be adopted by the payors and pharmaceutical companies. The technology used allow the products to be very small and lightweight.

Its smart thermal shield combines a unique ultrahigh vacuum thermal insulation and a small amount of heat absorbing phase change material and uses our unique thermal design. This combination blocks and absorbs heat during the entire day time, and releases the absorbed heat back to the environment overnight, regaining its heat absorbing capacity for the following day, without any intervention.

Funding history · 3 rounds · $10.2M total

2025-10
PIPE $1.8M
2025-09
Undisclosed $5.4M
2021-12
Series A $1.8M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsLaboratoriesMedical Devices IndustryMedical ProductsLife SciencesBiotechnologyPharmaceuticals
Business model
B2CB2BB2B2C

Highlights

1 PatentsVerified

Tags

pharma-companieschronic-diseasesupply-chainpatientspharmaceuticalsdiabetesmonitoringmedical-productstype-2-diabetescoolingmedical-devicesstorage